MedCity News

Revolution Medicines Receives Landmark FDA Drug Approval in Pancreatic Cancer

Stop Pitching the Institute — Pitch the Stack

Health-tech pilots don't usually fail because the product is bad. They fail because the system was never wired to absorb it.

By Mitchell Frye

Artificial Intelligence, Health Tech, Consumer / Employer, Legal

Woman wearing smart ring on her hand. Concept sport and healthy lifestyle

Why Oura’s Sleep-Tracking Lawsuit Is Really About Trust

A new class action lawsuit accuses Oura of overstating its smart ring's sleep tracking accuracy, arguing the device relies on AI-generated estimates rather than the clinical measurements needed for true sleep staging. The case is reigniting questions about how much precision consumers should expect from AI-powered health wearables.

By Katie Adams

Consumer / Employer

Rising Healthcare costs and higher health care prices as increase in medication and prescription medications or unaffordable hospital bills represented by a Doctor stethoscope and upward arrow.

Business Group on Health: Employer Healthcare Costs Projected to Rise 9.2% in 2027

Employers expect healthcare costs to rise 9.2% in 2027 as they seek ways to curb rising hospital and pharmacy costs.

By Marissa Plescia

Latest Video

Latest News

BioPharma, Pharma

J&J’s Imaavy Becomes First FDA-Approved Therapy for Rare Form of Anemia

Johnson & Johnson antibody drug Imaavy expanded its label to include the treatment of warm autoimmune hemolytic anemia (wAIHA). Projected to become a blockbuster seller across multiple indications, Imaavy was first approved last year for treating generalized myasthenia gravis.

By Frank Vinluan

MedCity Influencers

Before You Sign That AI Contract: 7 Questions Every Healthcare CFO Should Ask

Here's how finance leaders can evaluate AI investments in revenue cycle management before committing budget, and the risk exposure most vendor pitches leave out.

By Purnendu Bala

Where Will AI Deployment Benefit Payers the Most?

We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.

By MedCity News

Health Tech, Hospitals, Providers

Scalable to any size. Vector illustration file.

4 Patients Injured After Drug Mix-Up at Ascension Hospital in Nashville

A pharmacy error at an Ascension hospital in Nashville left four joint replacement patients injected with potassium phosphate instead of spinal anesthetic. The mix-up paralyzed one patient and harmed the other three. The Tennessee Bureau of Investigation is now probing the case.

By Katie Adams

Health Tech

Amazon Taps Expressable for Health Benefits Connector

Expressable has joined Amazon’s Health Benefits Connector to help families access virtual speech therapy through their insurance.

By Marissa Plescia

BioPharma, Pharma

Roche Gains Rights to Hanmi Obesity Drug That Reduces Fat, Preserves Muscle

Hanmi Pharmaceutical’s drug is designed to activate a receptor in skeletal muscle to both increase muscle mass and reduce fat. This engineered peptide gives Roche a clinical-stage asset that addresses a different target than the other obesity drugs in its pipeline.

By Frank Vinluan

MedCity Influencers

Sad woman crying watercolor painting texture on white background, mental health, illness ,brain development ,medical treatment concept

Why Psychiatry Can’t Ignore Metabolic Health Anymore

Metabolic psychiatry has moved past being a fringe theory. It is a practical, evidence-based necessity for a field that has been stagnant for too long.

By Scott Fears

Artificial Intelligence, Health Tech, Providers

Male doctor working on laptop in exam room

Ambient Scribes Improve Clinician Retention, Cleveland Clinic Research Shows

A new paper shows Cleveland Clinic's AI scribe rollout is paying dividends in clinician satisfaction and retention. These are key metrics for hospitals to track, given they spend millions on recruitment and retention efforts amid an ongoing workforce crisis.

By Katie Adams

BioPharma, Startups

Abcuro Adds $66M to Try Again in Rare Inflammatory Disorder With No Approved Drugs

Abcuro will apply the capital to a study that could support a biologics license application in inclusion body myositis, a rare inflammatory disorder that leads to worsening muscle weakness. A Phase 2/3 study failed earlier this year, but Abcuro saw positive trends in patients with less severe disease.

By Frank Vinluan

Health Tech, Payers

Cityblock to Acquire Homeward Health, Secures $116M Series E

Cityblock Health plans to acquire rural healthcare provider Homeward Health and has raised $116 million to expand its value-based care model to rural and Medicare Advantage populations.

By Marissa Plescia

MedCity Influencers

Woman embracing daughter while looking at female nurse holding clipboard - impact of Medicaid cuts.

How to Prepare Your Hospital Before H.R. 1 Hits in 2027

But the deadline that most people are not tracking, and the most worrisome, is October 1, 2026. It’s the day federal Medicaid funding ends for the country’s most vulnerable populations, including refugees, asylees, and humanitarian parolees.

By Scott Schrader

Artificial Intelligence, Health Tech

This Week In Epic News: FTC Probe, AI Agents & More

Epic faced an FTC antitrust probe this week, but that didn't stop the EHR giant from unveiling a wave of new AI tools at its annual conference.

By Katie Adams

BioPharma, Pharma

Ambros Therapeutics’ Path for Pain Drug Goes Through Reverse Merger With Werewolf

Along with Ambros Therapeutics’ merger with Werewolf Therapeutics, the combined company will raise $150 million in a private placement. Ambros is in Phase 3 testing with a drug developed for treating a type of pain that does not respond to currently available medicines, including opioids.

By Frank Vinluan

MedCity Influencers

The Pulse of Innovation: How 3D Models Can Prepare Surgeons for the Operating Room

Today, 3D modeling and printing technology can make a dramatic impact — even shortening some operations by 30-90 minutes. Looking ahead, that reduction will only grow as the technology is further integrated and becomes more advanced.

By Justin Ryan

MedCity Influencers

Wooden mannequin holding a US $100 dollar bill on a defocused stethoscope background.

Modernizing Payment Integrity in an Era of Systemic Fraud

Gaps in reimbursement oversight and recovery will only widen, unless plans modernize how they detect, investigate, and recoup improper payments.

By Christian Bass